{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:34Z","timestamp":1707524554189},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,12]]},"DOI":"10.7759\/cureus.25874","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T16:59:30Z","timestamp":1655053170000},"source":"Crossref","is-referenced-by-count":1,"title":["Tacrolimus-Induced Thrombotic Microangiopathy After Orthotopic Heart Transplant: A Case Report"],"prefix":"10.7759","author":[{"given":"Rajwinder","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Meghrajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-925475","article-title":"Thrombotic microangiopathy in transplantation and malignancy","volume":"31","author":"Qu L","year":"2005","unstructured":"Qu L, Kiss JE. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost. 2005, 31:691-9. 10.1055\/s-2005-925475","journal-title":"Semin Thromb Hemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12048","article-title":"Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients","volume":"43","author":"Nwaba A","year":"2013","unstructured":"Nwaba A, MacQuillan G, Adams LA, et al.. Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients. Intern Med J. 2013, 43:328-33. 10.1111\/imj.12048","journal-title":"Intern Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: a general approach to diagnosis and management","volume":"189","author":"Arnold DM","year":"2017","unstructured":"Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ. 2017, 189:E153-9. 10.1503\/cmaj.160142","journal-title":"CMAJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2018.0327","article-title":"The differential diagnosis and treatment of thrombotic microangiopathies","volume":"115","author":"Bommer M","year":"2018","unstructured":"Bommer M, W\u00f6lfle-Guter M, Bohl S, Kuchenbauer F. The differential diagnosis and treatment of thrombotic microangiopathies. Dtsch Arztebl Int. 2018, 115:327-34. 10.3238\/arztebl.2018.0327","journal-title":"Dtsch Arztebl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124070-00002","article-title":"Drug-induced thrombotic microangiopathy: incidence, prevention and management","volume":"24","author":"Pisoni R","year":"2001","unstructured":"Pisoni R, Ruggenenti P, Remuzzi G. Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf. 2001, 24:491-501. 10.2165\/00002018-200124070-00002","journal-title":"Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00212","article-title":"An update in drug-induced thrombotic microangiopathy","volume":"7","author":"Chatzikonstantinou T","year":"2020","unstructured":"Chatzikonstantinou T, Gavriilaki M, Anagnostopoulos A, Gavriilaki E. An update in drug-induced thrombotic microangiopathy. Front Med (Lausanne). 2020, 7:212. 10.3389\/fmed.2020.00212","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri ZL","year":"2015","unstructured":"Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015, 125:616-8. 10.1182\/blood-2014-11-611335","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu F","year":"2014","unstructured":"Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2014, 25:55-64. 10.1681\/ASN.2013050453","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock GA","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991, 325:393-7. 10.1056\/NEJM199108083250604","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George JN","year":"2010","unstructured":"George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010, 116:4060-9. 10.1182\/blood-2010-07-271445","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre CM","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, et al.. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013, 368:2169-81. 10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/2324709620947266","article-title":"The use of eculizumab in tacrolimus-induced thrombotic microangiopathy","volume":"8","author":"Gabr JB","year":"2020","unstructured":"Gabr JB, Bilal H, Mirchia K, Perl A. The use of eculizumab in tacrolimus-induced thrombotic microangiopathy. J Investig Med High Impact Case Rep. 2020, 8:2324709620947266. 10.1177\/2324709620947266","journal-title":"J Investig Med High Impact Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101424-tacrolimus-induced-thrombotic-microangiopathy-after-orthotopic-heart-transplant-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:49Z","timestamp":1707507889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101424-tacrolimus-induced-thrombotic-microangiopathy-after-orthotopic-heart-transplant-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,12]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.25874","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,12]]}}}